Instil Bio Stock Alpha and Beta Analysis
| TIL Stock | USD 7.00 0.39 5.28% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Instil Bio. It also helps investors analyze the systematic and unsystematic risks associated with investing in Instil Bio over a specified time horizon. Remember, high Instil Bio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Instil Bio's market risk premium analysis include:
Beta 1.43 | Alpha (1.14) | Risk 7.61 | Sharpe Ratio (0.17) | Expected Return (1.29) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Instil Bio Backtesting, Instil Bio Valuation, Instil Bio Correlation, Instil Bio Hype Analysis, Instil Bio Volatility, Instil Bio History and analyze Instil Bio Performance. Instil Bio Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Instil Bio market risk premium is the additional return an investor will receive from holding Instil Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Instil Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Instil Bio's performance over market.| α | -1.14 | β | 1.43 |
Instil Bio expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Instil Bio's Buy-and-hold return. Our buy-and-hold chart shows how Instil Bio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Instil Bio Market Price Analysis
Market price analysis indicators help investors to evaluate how Instil Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Instil Bio shares will generate the highest return on investment. By understating and applying Instil Bio stock market price indicators, traders can identify Instil Bio position entry and exit signals to maximize returns.
Instil Bio Return and Market Media
The median price of Instil Bio for the period between Sat, Oct 11, 2025 and Fri, Jan 9, 2026 is 12.77 with a coefficient of variation of 26.94. The daily time series for the period is distributed with a sample standard deviation of 3.82, arithmetic mean of 14.19, and mean deviation of 3.34. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Why Instil Bio Inc. stock remains on buy lists - Weekly Trend Recap Daily Profit Maximizing Trade Tips - newser.com | 10/27/2025 |
2 | Why Instil Bio Inc. stock appeals to analysts - 2025 Growth vs Value Real-Time Volume Triggers - newser.com | 10/31/2025 |
3 | Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer | 11/03/2025 |
4 | Is Instil Bio Inc. stock attractive for long term wealth building - July 2025 Action Verified Swing Trading Watchlist - newser.com | 11/06/2025 |
5 | Instil Bio Narrows Losses And Impresses Wall Street Analysts - Finimize | 11/12/2025 |
6 | Is Instil Bio Inc. stock attractive for long term wealth building - Weekly Trade Recap High Return Trade Opportunity Guides - newser.com | 11/14/2025 |
7 | Citizens reiterates Market Perform rating on Instil Bio stock - Investing.com | 11/18/2025 |
8 | Why analysts remain bullish on Instil Bio Inc. stock - Market Entry Points Low Cost Stock Picks - Bollywood Helpline | 12/24/2025 |
9 | Instil Bios Subsidiary Discontinues Clinical Development of AXN-2510 and Terminates License and Collaboration Agreement with ImmuneOnco | 01/06/2026 |
About Instil Bio Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Instil or other stocks. Alpha measures the amount that position in Instil Bio has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 | 2026 (projected) | PB Ratio | 0.73 | 0.84 | 0.8 | Capex To Depreciation | 2.77 | 3.19 | 3.03 |
Instil Bio Upcoming Company Events
As portrayed in its financial statements, the presentation of Instil Bio's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Instil Bio's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Instil Bio's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Instil Bio. Please utilize our Beneish M Score to check the likelihood of Instil Bio's management manipulating its earnings.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 29th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Instil Bio
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Instil Bio Backtesting, Instil Bio Valuation, Instil Bio Correlation, Instil Bio Hype Analysis, Instil Bio Volatility, Instil Bio History and analyze Instil Bio Performance. For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Instil Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.